The delivery of siRNAs to specific tissues can be challenging due to their instability and potential for degradation by nucleases. Common delivery methods include lipid nanoparticles, viral vectors, and conjugation with targeting molecules. Each method has its own advantages and limitations, depending on the tissue type and experimental requirements.
